Short-term insulin requirements following gastric bypass surgery in severely obese women with type 1 diabetes

Obesity Surgery

Volumn 24, Issue 9, 2014, Pages 1442-1446

  Middelbeek, Roeland J W ^a,d   James Todd, Tamarra ^b,d   Patti, Mary Elizabeth ^a,c,d   Brown, Florence M ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c JOSLIN DIABETES CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Gastric bypass surgery; Insulin requirements; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; PRAMLINTIDE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; FEMALE; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; OBESITY; ONSET AGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STOMACH BYPASS; THERAPY EFFECT; WEIGHT REDUCTION; BLOOD; COHORT ANALYSIS; COMPLICATION; DIABETES MELLITUS, TYPE 1; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; OBESITY, MORBID; YOUNG ADULT;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MIDDLE AGED; OBESITY, MORBID; YOUNG ADULT;

EID: 84906233707     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-014-1228-8     Document Type: Article

References (18)

1. Adams TD et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-61.
2. Mingrone G et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577-85.
3. Salinari S et al. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg. 2013;257(3):462-8.
4. Goldfine AB et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92(12):4678-85.
5. Saliba J, Wattacheril J, Abumrad NN. Endocrine and metabolic response to gastric bypass. Curr Opin Clin Nutr Metab Care. 2009;12(5):515-21.
6. Schauer PR et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-76.
7. Sjostrom L et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-93.
8. Czupryniak L et al. Gastric bypass surgery in severely obese type 1 diabetic patients. Diabetes Care. 2004;27(10):2561-2.
9. Mendez CE, Tanenberg RJ, Pories W. Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report. Diabetes Metab Syndr Obes. 2010;3:281-3.
10. Czupryniak L et al. Long-term results of gastric bypass surgery in morbidly obese type 1 diabetes patients. Obes Surg. 2010;20(4):506-8.
11. Raab H et al. Obesity and metabolic surgery in type 1 diabetes mellitus. Nutr Hosp. 2013;28 Suppl 2:31-4.
12. Conway B et al. Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med. 2010;27(4):398-404.
13. American Diabetes, A. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(Supplement 1):p. S67-74.
14. Lebovitz HE. Adjunct therapy for type 1 diabetes mellitus. Nat Rev Endocrinol. 2010;6(6):326-34.
15. Buchwald H et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):p. 248-256 e5.
16. Schauer PR et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467-84. discussion 84-5.
17. Muscelli E et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med. 2005;118(1):51-7.
18. Bojsen-Moller KN et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes. 2013. doi:10.2337/db13-1307.